Literature DB >> 8855316

A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.

B Dropulić1, M Hĕrmánková, P M Pitha.   

Abstract

Defective-interfering viruses are known to modulate virus pathogenicity. We describe conditionally replicating HIV-1 (crHIV) vectors that interfere with wild-type HIV-1 (wt-HIV) replication and spread. crHIV vectors are defective-interfering HIV genomes that do not encode viral proteins and replicate only in the presence of wt-HIV helper virus. In cells that contain both wt-HIV and crHIV genomes, the latter are shown to have a selective advantage for packaging into progeny virions because they contain ribozymes that cleave wt-HIV RNA but not crHIV RNA. A crHIV vector containing a triple anti-U5 ribozyme significantly interferes with wt-HIV replication and spread. crHIV vectors are also shown to undergo the full viral replicative cycle after complementation with wt-HIV helper-virus. The application of defective interfering crHIV vectors may result in competition with wt-HIVs and decrease pathogenic viral loads in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855316      PMCID: PMC38291          DOI: 10.1073/pnas.93.20.11103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.

Authors:  C J Chen; A C Banerjea; G G Harmison; K Haglund; M Schubert
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

Review 2.  Small catalytic RNAs.

Authors:  R H Symons
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 3.  Genetic diversity and evolution of retroviruses.

Authors:  J M Coffin
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

4.  Human immunodeficiency virus vectors for inducible expression of foreign genes.

Authors:  G L Buchschacher; A T Panganiban
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Sequence requirements of the hammerhead RNA self-cleavage reaction.

Authors:  D E Ruffner; G D Stormo; O C Uhlenbeck
Journal:  Biochemistry       Date:  1990-11-27       Impact factor: 3.162

6.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.

Authors:  J H Richardson; L A Child; A M Lever
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 8.  Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo.

Authors:  L Roux; A E Simon; J J Holland
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

9.  Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.

Authors:  R E Benson; A Sanfridson; J S Ottinger; C Doyle; B R Cullen
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.

Authors:  M H Malim; W W Freimuth; J Liu; T J Boyle; H K Lyerly; B R Cullen; G J Nabel
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Gene therapy for HIV.

Authors:  A M Lever
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

2.  Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.

Authors:  M R Mautino; N Keiser; R A Morgan
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Mobilization-competent Lentiviral Vector-mediated Sustained Transcriptional Modulation of HIV-1 Expression.

Authors:  Anne-Marie W Turner; Justin De La Cruz; Kevin V Morris
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

4.  Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.

Authors:  S Koseki; T Tanabe; K Tani; S Asano; T Shioda; Y Nagai; T Shimada; J Ohkawa; K Taira
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  A mathematical model of HIV dynamics in the presence of a rescuing virus with replication deficiency.

Authors:  Elias Zintzaras; Axel Kowald
Journal:  Theory Biosci       Date:  2011-01-29       Impact factor: 1.919

6.  Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.

Authors:  Touraj Farazmandfar; Mohammad Reza Haghshenas; Majid Shahbazi
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 5.695

7.  Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV.

Authors:  Pablo Tebas; David Stein; Gwendolyn Binder-Scholl; Rithun Mukherjee; Troy Brady; Tessio Rebello; Laurent Humeau; Michael Kalos; Emmanouil Papasavvas; Luis J Montaner; Daniel Schullery; Farida Shaheen; Andrea L Brennan; Zhaohui Zheng; Julio Cotte; Vladimir Slepushkin; Elizabeth Veloso; Adonna Mackley; Wei-Ting Hwang; Faten Aberra; Jenny Zhan; Jean Boyer; Ronald G Collman; Frederic D Bushman; Bruce L Levine; Carl H June
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

Review 8.  Novel cell and gene therapies for HIV.

Authors:  James A Hoxie; Carl H June
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

9.  HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.

Authors:  Lingbing Zeng; Vicente Planelles; Ziye Sui; Suzanne Gartner; Sanjay B Maggirwar; Stephen Dewhurst; Linbai Ye; Vivek R Nerurkar; Richard Yanagihara; Yuanan Lu
Journal:  J Gene Med       Date:  2006-01       Impact factor: 4.565

10.  Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance.

Authors:  Xiaobin Lu; Qiao Yu; Gwendolyn K Binder; Ziping Chen; Tatiana Slepushkina; John Rossi; Boro Dropulic
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.